经口激光显微手术治疗老年声门癌:疗效与安全性
回顾性分析72例接受经口激光显微手术(TLM)的老年声门癌患者(≥70岁,平均76岁;63例pT1,9例pT2),术后并发症8%,无治疗相关死亡,局部复发16.5%,5年疾病特异性生存95%、总生存68%、无喉切除生存88%;文献综述提示TLM安全有效。
要点
- 老年声门癌患者TLM术后并发症6例(8%),无治疗相关死亡。
- 局部复发12例(16.5%):pT1为9例(14%),pT2为3例(33%)。
- 5年DSS 95%、OS 68%、无喉切除生存88%。
核心结论
- 本研究结果和文献信息显示,TLM治疗老年声门癌可获得满意的治疗结果。
研究设计与样本
- 回顾性研究纳入72例连续老年声门癌患者(≥70岁,平均76岁;63例pT1,9例pT2),均接受TLM治疗,并进行系统文献综述。
主要发现
- 术后并发症6例(8%),无治疗相关死亡。
- 局部复发12例(16.5%):pT1为9例(14%),pT2为3例(33%)。
- 5年疾病特异性生存95%、总生存68%、无喉切除生存88%。
- 文献综述提示TLM安全有效,并发症少,局部控制率>85%,DSS>90%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data about the results of transoral laser microsurgery (TLM) in elderly patients are limited. METHODS: A retrospective study of 72 consecutive cases of glottic carcinoma (63 pT1 and 9 pT2 cases) in elderly patients (≥70 years old, mean 76 years) treated with TLM was made. A systematic review of the literature was performed. RESULTS: Six patients (8%) had postoperative complications, but no treatment-related deaths were observed. Local recurrences occurred in 12 patients (16.5%): nine with pT1 (14%) and three with pT2 (33%) tumors. Five-year disease-specific survival (DSS), overall survival, and laryngectomy-free survival were 95%, 68%, and 88%, respectively. The literature review indicated that TLM is safe and effective treatment for these patients, with few complications and good local control (>85%) and DSS (>90%) rates. CONCLUSIONS: Our results and the information from the literature show that TLM for glottic cancer in elderly patients can lead to satisfactory treatment results.
引用
- Rodrigo JP, García-Velasco F, Ambrosch P, et al. Transoral laser microsurgery for glottic cancer in the elderly: Efficacy and safety. Head Neck. 2019. PMID: 30636186. doi:10.1002/hed.25616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。